Immunomedics (IMMU) Misses Q4 EPS by 46c
Tweet
Share
E-mailGet Alerts IMMU Hot Sheet
Price: $87.86 --0%
Financial Fact:
Foreign currency transaction gain: 2.46K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Financial Fact:
Foreign currency transaction gain: 2.46K
Today's EPS Names:
VIVO, PMCB, PLCE, More
Join SI Premium – FREE
Immunomedics (NASDAQ: IMMU) reported Q4 EPS of ($0.68), $0.46 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $400 thousand versus the consensus estimate of $4.27 million.
For earnings history and earnings-related data on Immunomedics (IMMU) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ciena beats estimates on strong AI-driven demand, shares rise
- Ciena (CIEN) Tops Q3 EPS by 39c, Offers Guidance
- Alight names Bruce Wolfe as SVP, Wealth Solution Leader
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
